About Us

arrow-icon
Back to About Us
member-photo-1

Rev. Nicanor Pier Giorgio Austriaco, O.P., Ph.D., S.T.D.

Associate Scholar

Rev. Nicanor Austriaco, O.P., completed his Bachelor’s Degree (B.S.E.) in Bioengineering, summa cum laude, at the University of Pennsylvania, and then earned his Ph.D. in Biology from M.I.T. in the laboratory of Professor Leonard Guarente, where he was a fellow of the Howard Hughes Medical Institute (HHMI). He was ordained a priest in the Order of Preachers in May of 2004. He completed his Pontifical License in Sacred Theology (S.T.L.) in Moral Theology, summa cum laude, at the Dominican House of Studies in Washington, DC, in 2005, and a Pontifical Doctorate in Sacred Theology (S.T.D.), magna cum laude, at the University of Fribourg in Switzerland, in 2015. He earned his MBA at Providence College in 2020.

Fr. Austriaco currently serves as Professor of Biology and of Theology at Providence College in Providence, Rhode Island. He is also a Professor of Biological Sciences and a Professor of Sacred Theology at the University of Santo Tomas in Manila, Philippines, and director of ThomisticEvolution.org. His NIH-funded laboratory at Providence College is investigating the genetics of programmed cell death using the yeasts, Saccharomyces cerevisiae and Candida albicans, as model organisms. Papers describing his research have been published in PLoS ONE, FEMS Yeast Research, Microbial Cell, Cell, the Journal of Cell Biology, and the Proceedings of the National Academy of Sciences USA, among others. In philosophy and theology, his essays have been published in the National Catholic Bioethics QuarterlyTheological Studies, Nova et Vetera, The Thomist, Science and Theology, and the Linacre Quarterly. His first book, Biomedicine and Beatitude: An Introduction to Catholic Bioethics, was published by the Catholic University of America Press in 2011. It was recognized as a 2012 Choice outstanding academic title by the Association of College and Research Libraries.

Latest Research & News

  • Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines | September 30, 2020

    To view this chart as a PDF, see: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines   Updated June 2, 2021   Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine. One concern regarding the ethical assessment of […]

  • A Visual Aid to Viral Infection and Vaccine Production | June 15, 2020

    This is Issue 1 in CLI’s On Science. To view this report as a PDF, see: A Visual Aid to Viral Infection and Vaccine Production   Updated November 2020   Introduction As a result of the rapid spread of the new coronavirus technically known as SARS-CoV-2, the United States and other governments have begun crash […]

  • The Coronavirus Pandemic and the Ethics of Triage | March 26, 2020

    by R. J. Snell, Ph.D. This paper can be viewed as a pdf here: The Coronavirus Pandemic and the Ethics of Triage   As the COVID-19 pandemic continues in Italy, many hospitals are overwhelmed with patients, necessitating difficult triage decisions that can seem like choosing who lives and who dies. In the United States, already […]

  • Pro-Life Topics for Lawmakers Regarding Coronavirus | March 25, 2020

    This is Issue 43 in CLI’s On Point Series. To view this report as a PDF, see: On Point 43 Pro-Life Topics for Lawmakers Regarding Coronavirus.   Abortion advocates have found a new ally—COVID-19.   During this intensely stressful time, the vast majority of Americans are focused on protecting their health and the health of […]

  • Hydroxychloroquine Use During Pregnancy | April 20, 2020

    This is Issue 45 in CLI’s On Point Series. To view this report as a PDF, see: On Point 45 Hydroxychloroquine Use During Pregnancy   In recent weeks, hydroxychloroquine (HCQ) has received significant media attention because of initial reports that suggest that it could be an effective treatment for the highly infectious respiratory disease, COVID-19, […]